Litcius/Paper detail

Early Relapse After Autologous Transplant Is Associated With Very Poor Survival and Identifies an Ultra-High-Risk Group of Patients With Myeloma

Efstathios Kastritis, Μαρία Ρούσσου, Evangelos Eleutherakis‐Papaiakovou, Maria Gavriatopoulou, Magdalini Migkou, Dimitra Gika, Despina Fotiou, Nikolaos Kanellias, Dimitrios C. Ziogas, Ioannis Ntanasis‐Stathopoulos, Despoina Mparmparousi, Anastasia Gatou, Despina Katopi, Efstathios Manios, Michalis Liontos, Stavroula Giannouli, Panagiotis Tsirigotis, Evangelos Terpos, Meletios Α. Dimopoulos

2020Clinical Lymphoma Myeloma & Leukemia44 citationsDOI

Topics & Concepts

MedicineHazard ratioInternal medicineAutologous stem-cell transplantationOncologyMultivariate analysisMultiple myelomaRetrospective cohort studyLenalidomideSingle CenterSurgeryConfidence intervalMultiple Myeloma Research and TreatmentsAcute Myeloid Leukemia ResearchHematopoietic Stem Cell Transplantation
Early Relapse After Autologous Transplant Is Associated With Very Poor Survival and Identifies an Ultra-High-Risk Group of Patients With Myeloma | Litcius